XW0DXK8 ICD-10-PCS Code: Introduction of Sabizabulin into Mouth and Pharynx, External Approach, New Technology Group 8

Related Codes

Same operation — other Device / Substance / Technology

Same table and root operation, differing only in the device / substance / technology character.

XW0DX38 — Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8

Same procedure category (CCSR), other tables

AHRQ's Clinical Classifications Software Refined groups these ICD-10-PCS procedures with this one under Chemotherapy (Administration of Therapeutic Substances); listed here are the members in other PCS tables. Source: Clinical Classifications Software Refined (CCSR), Healthcare Cost and Utilization Project (HCUP), Agency for Healthcare Research and Quality, November 2025.

3E0Q705 — Introduction of Other Antineoplastic into Cranial Cavity and Brain, Via Natural or Artificial Opening, 3E0Q70M — Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Via Natural or Artificial Opening, 3E0R302 — Introduction of High-dose Interleukin-2 into Spinal Canal, Percutaneous Approach, 3E0R303 — Introduction of Low-dose Interleukin-2 into Spinal Canal, Percutaneous Approach, 3E0R305 — Introduction of Other Antineoplastic into Spinal Canal, Percutaneous Approach, 3E0R30M — Introduction of Antineoplastic, Monoclonal Antibody, into Spinal Canal, Percutaneous Approach, 3E0S302 — Introduction of High-dose Interleukin-2 into Epidural Space, Percutaneous Approach, 3E0S303 — Introduction of Low-dose Interleukin-2 into Epidural Space, Percutaneous Approach, 3E0S305 — Introduction of Other Antineoplastic into Epidural Space, Percutaneous Approach, 3E0S30M — Introduction of Antineoplastic, Monoclonal Antibody, into Epidural Space, Percutaneous Approach, 3E0U305 — Introduction of Other Antineoplastic into Joints, Percutaneous Approach, 3E0U30M — Introduction of Antineoplastic, Monoclonal Antibody, into Joints, Percutaneous Approach, 3E0V305 — Introduction of Other Antineoplastic into Bones, Percutaneous Approach, 3E0V30M — Introduction of Antineoplastic, Monoclonal Antibody, into Bones, Percutaneous Approach, 3E0W305 — Introduction of Other Antineoplastic into Lymphatics, Percutaneous Approach, 3E0W30M — Introduction of Antineoplastic, Monoclonal Antibody, into Lymphatics, Percutaneous Approach, 3E0Y305 — Introduction of Other Antineoplastic into Pericardial Cavity, Percutaneous Approach, 3E0Y30M — Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Percutaneous Approach, 3E0Y705 — Introduction of Other Antineoplastic into Pericardial Cavity, Via Natural or Artificial Opening, 3E0Y70M — Introduction of Antineoplastic, Monoclonal Antibody, into Pericardial Cavity, Via Natural or Artificial Opening, +127 more

Contextual Map

Every relationship of XW0DXK8 in one view: hierarchy, official tabular instructions in both directions, clinical classification, risk adjustment, MS-DRG participation, index terms and change history — each edge carrying the CMS source it derives from.

PCS table

• XW0[PCS table]— CMS ICD-10-PCS tables
• New Technology — Section: New Technology[Section]: “New Technology”— CMS ICD-10-PCS tables
• Anatomical Regions — Body System: Anatomical Regions[Body System]: “Anatomical Regions”— CMS ICD-10-PCS tables
• Introduction — Operation: Introduction[Operation]: “Introduction”— CMS ICD-10-PCS tables

Clinical classification (CCSR)

• ADM012 — Chemotherapy[CCSR category]: “Chemotherapy — Administration of Therapeutic Substances”— AHRQ CCSR for ICD-10-PCS Procedures (HCUP) · v2026.1

Nearest codes

• XW0DX38 — Introduction of Maribavir Anti-infective into Mouth and Pharynx, External Approach, New Technology Group 8[One axis away]— CMS ICD-10-PCS tables

Change history

• FY2023 (April) — Added to the code set[Change history]— CMS release files (code change ledger) · icd10pcs-fy2023apr